avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hes1
|
ENSMUSG00000022528.7 | hes family bHLH transcription factor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Hes1 | mm10_v2_chr16_+_30065333_30065351 | 0.22 | 2.1e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 8.5 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
2.2 | 24.2 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.9 | 4.3 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.7 | 2.1 | GO:2000978 | negative regulation of forebrain neuron differentiation(GO:2000978) |
0.5 | 4.4 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.5 | 1.6 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
0.5 | 2.9 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.5 | 2.3 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.4 | 2.1 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.4 | 1.2 | GO:0072299 | negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
0.4 | 2.4 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.3 | 1.3 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.3 | 0.9 | GO:2000451 | immune complex clearance by monocytes and macrophages(GO:0002436) astrocyte chemotaxis(GO:0035700) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) positive regulation of immune complex clearance by monocytes and macrophages(GO:0090265) negative regulation of eosinophil activation(GO:1902567) positive regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000451) regulation of astrocyte chemotaxis(GO:2000458) |
0.3 | 1.1 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.3 | 1.4 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.2 | 2.0 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.2 | 1.0 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.2 | 1.9 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.2 | 0.8 | GO:2000705 | negative regulation of anion channel activity(GO:0010360) regulation of dense core granule biogenesis(GO:2000705) |
0.2 | 0.6 | GO:1990523 | bone regeneration(GO:1990523) |
0.2 | 1.4 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.2 | 1.0 | GO:1904970 | brush border assembly(GO:1904970) |
0.2 | 1.5 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 1.8 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.2 | 2.6 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.2 | 0.8 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.2 | 7.4 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.2 | 0.7 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.2 | 0.5 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.2 | 0.8 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.2 | 0.5 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) positive regulation of dermatome development(GO:0061184) renal vesicle induction(GO:0072034) negative regulation of male gonad development(GO:2000019) |
0.2 | 0.5 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.1 | 5.7 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.1 | 0.4 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
0.1 | 1.2 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.1 | 1.4 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 0.9 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.1 | 0.5 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 0.7 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 2.0 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.8 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.5 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.1 | 0.3 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.1 | 0.6 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.4 | GO:0035087 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.1 | 0.3 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.1 | 0.4 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.2 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
0.1 | 0.8 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.7 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 0.7 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.5 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.9 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.3 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.1 | 0.6 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.2 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
0.1 | 0.2 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) response to laminar fluid shear stress(GO:0034616) negative regulation of interleukin-8 biosynthetic process(GO:0045415) cellular response to laminar fluid shear stress(GO:0071499) |
0.1 | 0.3 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.1 | 0.6 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 3.0 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.1 | 0.9 | GO:0006415 | translational termination(GO:0006415) |
0.0 | 0.3 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.0 | 1.1 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.0 | 0.9 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.0 | 2.1 | GO:0021591 | ventricular system development(GO:0021591) |
0.0 | 2.7 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.0 | 0.9 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.0 | 2.5 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.3 | GO:0060157 | urea transport(GO:0015840) urinary bladder development(GO:0060157) |
0.0 | 0.8 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.3 | GO:0015670 | carbon dioxide transport(GO:0015670) one-carbon compound transport(GO:0019755) |
0.0 | 0.1 | GO:0072757 | cellular response to camptothecin(GO:0072757) |
0.0 | 2.3 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 2.6 | GO:0090501 | RNA phosphodiester bond hydrolysis(GO:0090501) |
0.0 | 0.2 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) positive regulation of phospholipid catabolic process(GO:0060697) |
0.0 | 0.1 | GO:0060032 | notochord regression(GO:0060032) |
0.0 | 0.2 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.4 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.0 | 0.3 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
0.0 | 0.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.4 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 2.4 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.0 | 0.2 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.0 | 0.6 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.0 | 0.6 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.0 | 0.5 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 0.2 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.0 | 0.7 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.5 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 1.2 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.1 | GO:0008358 | oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
0.0 | 0.2 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.0 | 0.2 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.0 | 0.4 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.0 | 0.5 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 0.2 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.9 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.0 | 0.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.0 | 1.1 | GO:0070527 | platelet aggregation(GO:0070527) |
0.0 | 0.9 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.0 | 0.2 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.3 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.6 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.4 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.6 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 0.1 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.0 | 0.1 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.0 | 0.4 | GO:0009409 | response to cold(GO:0009409) |
0.0 | 0.2 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 0.2 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.0 | 0.7 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.0 | 0.4 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 2.3 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.3 | 4.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.3 | 7.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.3 | 1.6 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.3 | 1.7 | GO:0000235 | astral microtubule(GO:0000235) |
0.2 | 0.8 | GO:0099522 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
0.2 | 1.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 3.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 2.1 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 2.1 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 0.8 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 1.0 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 1.6 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 0.9 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 4.3 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 1.3 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.7 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 0.7 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 1.0 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 1.4 | GO:0016580 | Sin3 complex(GO:0016580) |
0.1 | 0.2 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 1.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.9 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 1.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.8 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 0.2 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 0.8 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 0.2 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.0 | 0.7 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 3.3 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.6 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 1.1 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.9 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 0.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.0 | GO:0019034 | viral replication complex(GO:0019034) |
0.0 | 0.4 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 1.5 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.3 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.2 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.2 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.0 | 0.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.4 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.0 | 0.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.1 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 2.5 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 2.0 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 1.0 | GO:0043198 | dendritic shaft(GO:0043198) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 4.3 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
1.0 | 3.1 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
0.7 | 7.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.6 | 1.8 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.5 | 4.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.5 | 5.6 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.5 | 24.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.4 | 4.4 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.4 | 2.6 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.3 | 2.4 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.3 | 0.9 | GO:0035717 | chemokine (C-C motif) ligand 7 binding(GO:0035717) |
0.3 | 0.9 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.3 | 1.4 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.3 | 0.8 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.2 | 0.7 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.2 | 0.2 | GO:0031762 | alpha-1A adrenergic receptor binding(GO:0031691) alpha-1B adrenergic receptor binding(GO:0031692) follicle-stimulating hormone receptor binding(GO:0031762) |
0.2 | 0.9 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.2 | 1.6 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 8.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 0.7 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 1.2 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.2 | 0.5 | GO:0035939 | microsatellite binding(GO:0035939) |
0.1 | 1.1 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.5 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.1 | 1.3 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.6 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.1 | 0.9 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.7 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 1.0 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 0.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.3 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
0.1 | 2.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.5 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.1 | 0.7 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 1.2 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 1.1 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.4 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 2.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 1.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 3.4 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 1.6 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.1 | 2.9 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 1.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 1.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.2 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.0 | 0.5 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.3 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 0.5 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.1 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.6 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 1.2 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.0 | 1.2 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.0 | 1.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.3 | GO:0051870 | methotrexate binding(GO:0051870) |
0.0 | 3.2 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.2 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.0 | 0.9 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 1.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 1.6 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 0.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 1.6 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 2.1 | GO:0004519 | endonuclease activity(GO:0004519) |
0.0 | 0.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.7 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.7 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.1 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.7 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.6 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 25.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 4.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 2.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 4.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 2.4 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 1.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 1.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 1.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 1.9 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 4.3 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 2.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 1.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.5 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.0 | 1.1 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.8 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 24.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 7.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 0.9 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 1.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 2.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 4.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 3.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 1.8 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 4.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 1.2 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 2.7 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.1 | 3.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 4.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 2.9 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.1 | 1.0 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 0.8 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 2.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 1.2 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.5 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 0.3 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.1 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 1.1 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 1.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 3.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 4.8 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.9 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 1.5 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.0 | 0.9 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.3 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 0.8 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 1.7 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |